Please login to the form below
Teva and Novartis settle patent lawsuit
Teva Pharmaceuticals will settle patent litigation with Novartis involving Teva's US generic version of antiviral medication Famvir
Teva Pharmaceuticals, US, has signed an agreement with Novartis to settle patent litigation involving Teva's US generic version of the Novartis-developed antiviral medication Famvir (famciclovir).
The settlement includes all claims for patent infringement and damages.
Under the terms of the agreement, Israel-based Teva will make an undisclosed one-time payment to Novartis plus ongoing royalties on US sales of its product, which is used to treat herpes and shingles.
Teva is among the top 15 global pharmaceutical companies and is a leading generic pharmaceutical company. Teva launched the generic version of Famvir in September 2007.
Share
Related Hub content
Featured jobs
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Scientific Director
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- Freelance Senior Account Manager – healthcare advertising
-
Employment Type:. Healthcare Advertising Jobs. Salary:. 250 to 320 per day
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Director or Senior Account Director
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Market Access Consultant - Cheshire
-
Negotiable
-
Senior Medical Writer
-
Great salary and bebefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
starting from £32, 500
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Medical Director
-
Excellent benefits
Subscribe to our email news alerts
- How can pharma engage with key stakeholders on NHS service transformation?
- The race for an HIV ‘cure’
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Novo spends $800m to buy biotech and 'glucose responsive insulin' tech
- Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more
- Armoured CAR ‘could overwhelm solid tumour resistance’
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- How can pharma engage with key stakeholders on NHS service transformation?
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
- The race for an HIV ‘cure’
- Supercharging therapies as pharma and patients work together...
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....
Quick links
Infographics
